Plasmid DNA from 30 selected MRSA strains were electroporated into S. aureus ATCC29213 as previously described by Lannergard et al. [8] with minor modifi cations.
energy-dependent effl ux, (ii) production of inactivating enzymes and (iii) alteration of 23S rRNA methylases. [2] On the other hand, tetracycline resistance is mediated by enzyme inactivation, ribosomal protection proteins and effl ux proteins. [3] Currently, there is no report on the distribution of erythromycin and tetracycline-resistance genes among MRSA strains in Malaysia. Thus, this study was aimed at determining the expression and transferability of erythromycin and tetracycline resistance of MRSA strains isolated from a local teaching hospital in Malaysia.
Materials and Methods
In this study, 188 MRSA strains including 162 from our previous study, which were resistant to erythromycin, ciprofl oxacin or tetracycline, were further analysed. The remaining new strains were obtained from the year 2004 (n=9), 2007 (n=16) and 2008 (n=1).
Polymerase chain reaction (PCR) for the detection of resistance genes for erythromycin (ermA, ermB, ermC and msrA), tetracycline (tetK, tetL, tetM, tetO and tetS), β-lactams (blaZ) and tetracycline transposon-associated genes (Tn916 and Tn5801) were carried out as previously described [4] [5] [6] [7] using both genomic and plasmid DNA as PCR templates.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is an important bacterial pathogen associated with community (CA) and health-care (HA) infections in Malaysia and worldwide. A local study reported that the MRSA strains in Malaysia are often resistant to erythromycin, gentamicin and ciprofl oxacin. [1] In many cases, erythromycin resistance is also associated with the resistance to other macrolides, lincosamides and type B streptogramin (MLS B ). There are three mechanisms involved in erythromycin resistance: (i) the use of an Briefl y, 40 μl of electrocompetent cells were mixed with 2-5 μg of plasmid DNA, transferred to a 1-mm electroporation cuvette and electroporated using a Bio-Rad gene pulser (Bio-Rad Laboratories, Hercules CA, USA). The gene pulser was set at 200 Ω resistance, 25 μF capacitance and 2.5 kV. Transformants were selected on Typtic Soy Agar plates supplemented with either erythromycin (50 μg/ml) or tetracycline (50 μg/ml).
The antimicrobial susceptibility of transformants to three antimicrobial agents [oxacillin (1 μg), tetracycline (30 μg) and erythromycin (15 μg) (Oxoid Ltd., Basingstoke, Hampshire, UK)] was determined by disc diffusion method. [9] The presence of erythromycin-resistance gene in transformants was detected by PCR as described earlier. Size determination of the plasmids extracted from transformants was carried out by digestion of plasmid DNA with EcoRI (Promega, Madison, WI, USA), and the products were separated in 0.8% agarose gel for 6 h at 90 V. 
Results
All strains were resistant to oxacillin (MIC 4-512 μg/ml). The MIC for erythromycin, ciprofl oxacin and tetracycline ranged from 0.25 to 256 μg/ml, 0.5 to 512 μg/ml and 0.5 to 256 μg/ml, respectively. The temporal changes in the MIC of four antimicrobials for MRSA are summarised in Table 1 . There was a signifi cant increase (P<0.05) of high-level erythromycin (128 and 256 μg/ml), medium-(16 μg/ml) to high-level tetracycline (256 μg/ml) and medium-level ciprofl oxacin (64 μg/ml) resistant strains between the years 2003 and 2008.
Based on Spearman's rank correlation coeffi cient test, the correlation between erythromycin and ciprofl oxacin resistance was observed (R=0.607, P<0.05). Similarly, correlations between erythromycin and tetracycline (R=0.1922, P<0.05), and ciprofl oxacin and tetracycline (R=0.0795, P<0.05) were also observed. The values indicate that tetracycline-resistant strains most likely to show co-resistance towards ciprofl oxacin and erythromycin. Similarly, these values also indicate that erythromycin-resistant strains were most likely to show co-resistance towards ciprofl oxacin and tetracycline.
Established primers for detection of erythromycin-, tetracycline-and β-lactam-resistance genes were carried out on genomic DNA of 188 MRSA strains. The results showed all erythromycin-resistant strains harboured either ermA, ermC or msrA gene and tetracycline-resistant strains harboured either tetK or tetM gene. Specifi cally, blaZ gene was detected in all strains, whereas ermA, tetM, ermC, tetK and msrA specifi c amplicons were detected in 157 (84%), 92 (49%), 40 (21%), 39 (21%) and 4 (2%) strains, respectively. However, no amplicon was obtained with primers that were specifi c for the ermB, tetL, tetO and tetS genes.
Majority (78%) of tetracycline-resistant strains harboured tetK and tetM genes with MIC ranging from 16 to 64 μg/ml. Based on the Kruskal-Wallis test, no signifi cant difference was found between the level of erythromycin resistance for 2008 strains and the presence of different types of erythromycin-resistance genes (H=5.29, df=2, P=0.071).
PCR amplifi cations using plasmid DNA as templates were carried out in parallel with additional 16S rRNA primers to preclude chromosomal DNA contamination. Results showed ermC, tetK, tetM and blaZ amplicons were detected with absence of 16S rRNA specifi c amplicon. This indicates that ermC, tetK, tetM and blaZ genes were plasmid-borne.
On the other hand, Tn5801-like transposon was detected in 78 tetM-positive strains, and no Tn916-like transposon was detected. Based on Spearman's rank correlation test, correlation between tetM and Tn5801 was observed (R=0.8647, P<0.05).
Plasmid analyses showed that 176 (94%) MRSA strains harboured 1-12 plasmids with sizes ranging from 1.9 to 169 kb. Transformation studies were performed on 30 randomly selected MRSA strains that harboured the plasmids. Plasmid transfers for erythromycin and tetracycline resistance were done by electroporation with the recipient S. aureus ATCC29213. However, the transfer only yielded success in 6 out of 30 strains for erythromycin resistance and no transfer of tetracycline resistance was observed. Further analysis showed that all resultant transformants were resistant to erythromycin (MIC 50-256 μg/ml). All transformants were sensitive to tetracycline since no tetracycline-resistance phenotype was transferred (based on the disc diffusion test).
Only ermC gene in the parental MRSA strains was successfully transferred into recipient S. aureus ATCC29213, suggesting that this resistant determinant was likely plasmid encoded. Plasmids of sizes ranging from 2.5 to 89 kb were detected in six transformants. Identical EcoRI restriction profi les were obtained from two plasmids extracted from donor MRSA (MRSA0812-1 and MRSA0804-1) and their respective transformants. The other plasmids extracted from transformants were smaller than plasmids from the donors. All the transformants which carried ermC contained plasmids with sizes of~2.5 to 2.7 kb.
Discussion
In our previous report, high oxacillin-, erythromycinand ciprofl oxacin-resistance rates were observed in 162 MRSA strains based on the disc diffusion test only. Signifi cant increase in tetracycline-resistance rate was also observed. Thus, we further extended the study to determine the association between MIC values and presence of resistance genes of erythromycin and tetracycline-resistant strains and its transferability.
The signifi cant increase of high-level tetracycline-(MIC≥256 μg/ml) and erythromycin (MIC≥128 μg/ml)-resistant strains between 2003 and 2008 along with the co-resistance between erythromycin, ciprofl oxacin and tetracycline is worrisome because choices of antimicrobial agents for treatment of life-threatening cases will be limited. Furthermore, use of tetracycline, ciprofl oxacin and erythromycin is still very common in Malaysian hospitals for treatment of respiratory tract and other nosocomial infections. [10] Erythromycin and tetracycline resistance is always attributed to the presence of resistance genes. In this study, the predominant resistance gene reported in erythromycin-resistant strains was ermA. This differs from the report by Spiliopoulou et al. [11] where most of their erythromycin-resistant strains harboured ermC gene. In addition, our results also showed that presence of different erythromycin-resistance genes (ermA, ermC and msrA) was not directly related to higher MIC values (based on Kruskal-Wallis test). For example, 31% of erythromycin-resistant strains that harboured ermA or ermC gene was associated with an MIC value of 8-64 μg/ml. However, this differs from the report by El-Madhy et al. [12] as all their ermC-positive strains displayed higher MIC values (MIC>1024 μg/ml). A majority of tetracycline-resistant strains harboured tetM (97%) followed by tetK (41%) gene. This is in contrast to reports by Jones et al. [13] and El-Madhy et al. [12] where tetK gene was the predominant gene in tetracycline-resistant strains. Spearman's rank correlation tests showed that a strain which harboured tetK gene also harboured tetM gene. This is in agreement with the report of Schmitz et al., [14] as their MRSA strains also harbour both tetK and tetM. Schmitz et al. [14] also reported that strains with both tetK and tetM genes often display higher MIC values than strains containing a single gene. In contrast, our study showed that the combination of tetK and tetM genes did not display higher MIC values as over 78% of the strains that harboured both tetK and tetM together were associated with an MIC value of 16-64 μg/ml. De Vries et al. [8] reported that tetM gene is located on both Tn5801-like and Tn916-like transposons. Their fi nding coincided with our data as majority (85%) of the tetM gene reported here was located on Tn5801-like conjugative transposon. Moreover, result of Spearman's rank correlation test also established the correlation between tetM and Tn5801.
Transformation experiments showed that only ermC was transmissible. Although Monecke et al. [15] reported that tetK gene is plasmid-borne and transmissible, none of the tetK genes was transferable in this study. Similarly, no tetM gene was transferable. Discrepancy observed might be due to the inherent property of recipient S. aureus ATCC29213 as Schenk and Laddaga [16] reported that this strain ATCC29213 has lower transformation effi ciency when compared to another recipient strain, RN4220.
Size of the plasmid carrying ermC gene reported in this study was similar to the plasmid size (2.5 kb) reported by Westh et al. [17] Based on the EcoR1 restriction profi les obtained, the size of plasmids that were isolated from the transformants (~2.5 to 81 kb) was slightly smaller than its donor (~2.5 to 89 kb). This was probably because the donor strains harboured more than a single type of plasmids.
In conclusion, tetracycline-resistant strains often showed co-resistance towards ciprofl oxacin and erythromycin. The ermA and tetM were the predominant genes detected in erythromycin-and tetracycline-resistant strains, respectively. The presence of ermA, ermC, tetM and tetK genes was responsible for erythromycin and tetracycline resistance among Malaysian MRSA strains. Association of resistance genes (ermC, tetM and tetK) with mobile genetic elements possibly enhances the spread of resistant traits in MRSA. The persistence of erythromycin, ciprofl oxacin and tetracycline resistance remains a problem in UMMC, and therefore good infection control procedures should be applied. This data set may act as a reference for monitoring erythromycin, tetracycline res istance among MRSA strains in Malaysia.
